Formulation and in Vitro Evaluation of Granisetron and Cabazitaxel Bilayered Tablets


Authors : Mamatha Kola; Anjali Sabavat; Rachana Balusukula; Phani Vennela Mudunuri; Mohammad Bakhatwar; Kabita Banik

Volume/Issue : Volume 10 - 2025, Issue 4 - April


Google Scholar : https://tinyurl.com/4f437ukk

Scribd : https://tinyurl.com/52d9yckv

DOI : https://doi.org/10.38124/ijisrt/25apr544

Google Scholar

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Note : Google Scholar may take 15 to 20 days to display the article.


Abstract : In the present study, the bilayered tablets were effectively formulated using Granisetron as immediate release layer and Cabazitaxel as controlled release layer by using direct compression method. Granisetron, an antagonist of the serotonin 5-HT3 receptor, is used as an antiemetic, while Cabazitaxel, an anticancer drug, is used to treat metastatic prostate cancer. Six Formulations of Granisetron and Cabazitaxel were prepared and evaluated for various physicochemical parameters such as hardness, friability and drug content. The optimized formulation GR-6 in immediate release layer formulation exhibited the average hardness of 4.3 kg/cm2 , friability of 0.40% and drug content 100.8%. The CB-6 as controlled release layer in formulation exhibited an average hardness of 3.4 kg/cm2 , friability of 0.42% and drug content 99.6% was determined. Both Granisetron and Cabazitaxel optimized layers were prepared as bilayered tablets by using polymers such as Ethyl cellulose, Eudragit, Guar gum, Hydroxypropyl cellulose and starch glycolate sodium. Cabazitaxel was released in a controlled manner in the first hour, while the remaining drug was released for up to 12 hours, and the Granisetron formulation showed 100.4% drug release.

Keywords : Bilayer tablet, Cancer, Immediate release, Control release, Hardness, Friability.

References :

  1. P. Mishra, P.K. Sharma, R. Malviya, A review on Bi-layer tablets-An emergingtrend, J. Drug Deliv.Therapeut. 4 (4) (2014) 110–114.
  2. S.S. Kale, V.S. Saste, P.L. Ughade, D.T. Baviskar, Bilayer tablet, Int. J. Pharmaceut. Sci. Rev. Res. 9 (1) (2011) 25–30.
  3. Laurence LB, John SL, Keith LP, editors. Goodman and Gilman' The Pharmacologic Basis of Therapeutics. 11 ed. New York: McGraw Hill Publishing Company; 2006. p. 1000-3.
  4. N. Abduljabbar H, M. Badr-Eldin S, M. Aldawsari , H. Gastroretentive ranitidine hydrochloride tablets with combined floating and bioadhesive properties: factorial design analysis, in vitro evaluation and in vivo abdominal X-ray imaging. Current drug delivery, 2015; 1, 12(5): 578-90.
  5. Rudnic EM, Kottke MK; Tablet dosage form. In Banker GS, Rhodes CT editors; Modern Pharmaceutics. 3rd edition, New York: Marcel Dekker Inc., 1996.
  6. Breech AJ, Lucisano LJ, Franz RM; Investigation into substrate cracking of a film coated bilayered tablet. J Pharm Pharmacol.,1998; 40(4): 282- 283.
  7. Kalam MA, Humayun M, Parvez N, Yadav S, Garg A, Amin S et al.; Release kinetics of modified pharmaceutical dosage forms: A Review, Continental J. Pharmaceutical Sciences; 2007; 1: 30 – 35.
  8. Li SP, Karth MG, Feld KM, Pendharkar CM, Willams RO; Evaluation of Bilayer tablet machines. A Case study. Drug Dev Ind Pharm., 1995; 21(5): 571-590. 20. Shukla S, PandyaV , Bhardia P, Jon
  9. Lachman L, Liberman H, Kanig J. The theory and practice of industrial pharmacy, 3rd edn. Varghese Publishing House, Mumbai, 1987, pp. 297
  10. Indian Pharmacopoeia 1996. The Controller of Publication. Delhi, Vol‐2, p‐735.
  11. Swamy P.V.*, Kinagi M. B., Biradar S. S., Gada S. N. and Shilpa H Department of Pharmaceutical Technology, HKE Society&39; s College of Pharmacy, Sedam Road, Gulbarga-585 105, Karnataka, India Indian Journal of Pharmaceutical Education and Research Association of Pharmaceutical Teachers of India
  12. Prasad BK, Remeth JD, Kailas KM, Vijay DH, Niranjan SM. Formulation and evaluation of mucoadhesive tablets of atenolol. J Pharm Res 2008; 1 (2): 193-9.
  13. Swamy PV, Kinagi MB, Biradar SS, Gada SN, Shilpa H; Formulation design and evaluation of bilayer buccal tablets of granisetron hydrochloride. Ind J Pharm Edu Res., 2011; 45(3): 242-247.
  14. Prasad BK, Remeth JD, Kailas KM, Vijay DH, Niranjan SM. Formulation and evaluation of buccoadhesive.

In the present study, the bilayered tablets were effectively formulated using Granisetron as immediate release layer and Cabazitaxel as controlled release layer by using direct compression method. Granisetron, an antagonist of the serotonin 5-HT3 receptor, is used as an antiemetic, while Cabazitaxel, an anticancer drug, is used to treat metastatic prostate cancer. Six Formulations of Granisetron and Cabazitaxel were prepared and evaluated for various physicochemical parameters such as hardness, friability and drug content. The optimized formulation GR-6 in immediate release layer formulation exhibited the average hardness of 4.3 kg/cm2 , friability of 0.40% and drug content 100.8%. The CB-6 as controlled release layer in formulation exhibited an average hardness of 3.4 kg/cm2 , friability of 0.42% and drug content 99.6% was determined. Both Granisetron and Cabazitaxel optimized layers were prepared as bilayered tablets by using polymers such as Ethyl cellulose, Eudragit, Guar gum, Hydroxypropyl cellulose and starch glycolate sodium. Cabazitaxel was released in a controlled manner in the first hour, while the remaining drug was released for up to 12 hours, and the Granisetron formulation showed 100.4% drug release.

Keywords : Bilayer tablet, Cancer, Immediate release, Control release, Hardness, Friability.

Never miss an update from Papermashup

Get notified about the latest tutorials and downloads.

Subscribe by Email

Get alerts directly into your inbox after each post and stay updated.
Subscribe
OR

Subscribe by RSS

Add our RSS to your feedreader to get regular updates from us.
Subscribe